Posted On: 09/16/2016 11:10:11 AM
Post# of 72447
"Upon joining Warner-Lambert Parke-Davis, her work included study director and writer in Pathology and Experimental Toxicology as well as Clinical Communications. As Director of Regulatory Affairs at Parke-Davis/Pfizer , she was therapeutic area lead in gene therapy and dermatology.....
“LaVonne is a fantastic addition to our team,” said Dr. Bertolino. “With our lead drug candidates approaching pivotal, later-stage FDA trials, LaVonne’s leadership in regulatory affairs will be of paramount importance as we continue to work closely with our research partners and the FDA towards further validating our drug candidates. The professional relationships that she has built over the years at the FDA, coupled with her extensive clinical and regulatory knowledge, should help ensure that lines of communication with the agency remain open and productive .”
- See more at: http://cellceutix.com/cellceutix-announces-ap...oyNq8.dpuf
“LaVonne is a fantastic addition to our team,” said Dr. Bertolino. “With our lead drug candidates approaching pivotal, later-stage FDA trials, LaVonne’s leadership in regulatory affairs will be of paramount importance as we continue to work closely with our research partners and the FDA towards further validating our drug candidates. The professional relationships that she has built over the years at the FDA, coupled with her extensive clinical and regulatory knowledge, should help ensure that lines of communication with the agency remain open and productive .”
- See more at: http://cellceutix.com/cellceutix-announces-ap...oyNq8.dpuf
(5)
(0)
